Cargando…
Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects
INTRODUCTION: Parkinson’s disease (PD), the second most common neurodegenerative disease after Alzheimer’s disease, affects 1% of the population after the age of 60. Motor symptoms are the most common features that may be associated with non-motor symptoms including psychotic symptoms. OBJECTIVES: F...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567882/ http://dx.doi.org/10.1192/j.eurpsy.2022.1194 |
_version_ | 1784809510490079232 |
---|---|
author | Nzamba Nzamba, D. Benallel, K. Kaddaf, A. Gartoum, M. Kadiri, M. |
author_facet | Nzamba Nzamba, D. Benallel, K. Kaddaf, A. Gartoum, M. Kadiri, M. |
author_sort | Nzamba Nzamba, D. |
collection | PubMed |
description | INTRODUCTION: Parkinson’s disease (PD), the second most common neurodegenerative disease after Alzheimer’s disease, affects 1% of the population after the age of 60. Motor symptoms are the most common features that may be associated with non-motor symptoms including psychotic symptoms. OBJECTIVES: Faire le point sur les modalités de prise en charge des symptômes psychotiques au cours de la maladie de Parkinson METHODS: Nous décrivons 3 cas de développement de symptômes psychotiques, survenus chez des patients atteints de la maladie de Parkinson, et faisons le point sur la prise en charge des manifestations symptomatiques psychiatriques dans la maladie de Parkinson, par une brève revue de la littérature. RESULTS: Case 1: 42-year-old man, with 5 years’ history of PD, presented with auditory hallucinations comorbid with paranoid personality disorder, which occurred 12 months following antiparkinsonian drugs use. Case 2: 58-year-old man, with 17 years’ history of PD, presented jealousy delusions and behavioral disorders, which occurred 12 years following antiparkinsonian drugs use. Case 3: 76-year-old man, with 36 years’ history of PD, presented visual hallucinations, subjective sensation of a presence and jealousy delusion, which occurred 26 years following antiparkinsonian drugs use. CONCLUSIONS: Les symptômes psychotiques de la maladie de Parkinson sont fréquents. La prise en charge consiste à traiter les symptômes psychotiques sans aggraver les symptômes moteurs liés à l’hypo-dopaminergie. DISCLOSURE: No significant relationships. |
format | Online Article Text |
id | pubmed-9567882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95678822022-10-17 Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects Nzamba Nzamba, D. Benallel, K. Kaddaf, A. Gartoum, M. Kadiri, M. Eur Psychiatry Abstract INTRODUCTION: Parkinson’s disease (PD), the second most common neurodegenerative disease after Alzheimer’s disease, affects 1% of the population after the age of 60. Motor symptoms are the most common features that may be associated with non-motor symptoms including psychotic symptoms. OBJECTIVES: Faire le point sur les modalités de prise en charge des symptômes psychotiques au cours de la maladie de Parkinson METHODS: Nous décrivons 3 cas de développement de symptômes psychotiques, survenus chez des patients atteints de la maladie de Parkinson, et faisons le point sur la prise en charge des manifestations symptomatiques psychiatriques dans la maladie de Parkinson, par une brève revue de la littérature. RESULTS: Case 1: 42-year-old man, with 5 years’ history of PD, presented with auditory hallucinations comorbid with paranoid personality disorder, which occurred 12 months following antiparkinsonian drugs use. Case 2: 58-year-old man, with 17 years’ history of PD, presented jealousy delusions and behavioral disorders, which occurred 12 years following antiparkinsonian drugs use. Case 3: 76-year-old man, with 36 years’ history of PD, presented visual hallucinations, subjective sensation of a presence and jealousy delusion, which occurred 26 years following antiparkinsonian drugs use. CONCLUSIONS: Les symptômes psychotiques de la maladie de Parkinson sont fréquents. La prise en charge consiste à traiter les symptômes psychotiques sans aggraver les symptômes moteurs liés à l’hypo-dopaminergie. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9567882/ http://dx.doi.org/10.1192/j.eurpsy.2022.1194 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Nzamba Nzamba, D. Benallel, K. Kaddaf, A. Gartoum, M. Kadiri, M. Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects |
title | Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects |
title_full | Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects |
title_fullStr | Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects |
title_full_unstemmed | Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects |
title_short | Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects |
title_sort | psychotic symptoms and parkinson’s disease: clinical and therapeutic aspects |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567882/ http://dx.doi.org/10.1192/j.eurpsy.2022.1194 |
work_keys_str_mv | AT nzambanzambad psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects AT benallelk psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects AT kaddafa psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects AT gartoumm psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects AT kadirim psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects |